Cargando…
Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis
BACKGROUND: More information about the impacts of comprehensive pharmaceutical care program (CPCP) on the identification and resolution of drug-related problems (DRPs) is needed. This study aimed at researching the characteristics of DRPs in osteoporosis patients and evaluating the effect of CPCP in...
Autores principales: | Chen, Wenwen, Zhang, Houli, Jiang, Juan, Zhang, Xu, Ding, Jing, Liu, Yanlin, Dang, Heqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706996/ https://www.ncbi.nlm.nih.gov/pubmed/36443812 http://dx.doi.org/10.1186/s12913-022-08862-x |
Ejemplares similares
-
Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study
por: Chen, Wenwen, et al.
Publicado: (2021) -
Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
por: Jiang, Juan, et al.
Publicado: (2023) -
Clinical characteristics, prescription patterns, and persistence associated with sacubitril/valsartan adoption: A STROBE-compliant study
por: Chen, Wenwen, et al.
Publicado: (2021) -
Drug-related problems identified during pharmaceutical care interventions in an intensive care unit at a tertiary university hospital
por: Tharanon, Vichapat, et al.
Publicado: (2022) -
Addressing
the Osteoporosis Problem—Multifunctional
Injectable Hybrid Materials for Controlling Local Bone Tissue Remodeling
por: Gilarska, Adriana, et al.
Publicado: (2021)